Dr. Michael Eagan, MD

NPI: 1003965237
Total Payments
$113.43
2024 Payments
$20.00
Companies
5
Transactions
8
Medicare Patients
1,666
Medicare Billing
$247,723

Payment Breakdown by Category

Food & Beverage$93.43 (82.4%)
Education$20.00 (17.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $93.43 7 82.4%
Education $20.00 1 17.6%

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $27.90 2 $0 (2019)
AstraZeneca Pharmaceuticals LP $25.67 2 $0 (2018)
E.R. Squibb & Sons, L.L.C. $24.96 2 $0 (2021)
CSL Behring $20.00 1 $0 (2024)
Allergan Inc. $14.90 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $20.00 1 CSL Behring ($20.00)
2021 $12.72 1 E.R. Squibb & Sons, L.L.C. ($12.72)
2019 $12.69 1 Janssen Pharmaceuticals, Inc ($12.69)
2018 $28.54 2 Allergan Inc. ($14.90)
2017 $39.48 3 Janssen Pharmaceuticals, Inc ($15.21)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
02/28/2024 CSL Behring Kcentra (Biological) Education In-kind items and services $20.00 General
Category: Trauma (Emergency, Injury, Surgery)
03/09/2021 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $12.72 General
Category: Cardiovascular
11/22/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $12.69 General
Category: Cardiovascular & Metabolism
04/25/2018 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $13.64 General
Category: Cardiovascular and Metabolism
01/26/2018 Allergan Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $14.90 General
Category: ANTI-INFECTIVE
11/08/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug), XARELTO, XARELTO Food and Beverage In-kind items and services $15.21 General
Category: Cardiovascular & Metabolism
11/08/2017 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $12.24 General
Category: Cardiovascular
01/11/2017 AstraZeneca Pharmaceuticals LP BRILINTA (Drug) Food and Beverage In-kind items and services $12.03 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 404 419 $624,208 $56,405
2022 4 416 429 $633,200 $61,009
2021 4 344 359 $527,542 $53,596
2020 5 502 520 $778,141 $76,712
Total Patients
1,666
Total Services
1,727
Medicare Billing
$247,723
Procedure Codes
17

All Medicare Procedures & Services

17 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99285 Emergency department visit with high level of medical decision making Facility 2023 246 258 $419,531 $38,079 9.1%
99284 Emergency department visit with moderate level of medical decision making Facility 2023 97 100 $108,998 $9,587 8.8%
99291 Critical care, first 30-74 minutes Facility 2023 42 42 $81,828 $7,647 9.3%
99283 Emergency department visit with low level of medical decision making Facility 2023 19 19 $13,851 $1,092 7.9%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 280 291 $459,471 $43,963 9.6%
99291 Critical care, first 30-74 minutes Facility 2022 46 46 $85,192 $8,717 10.2%
99284 Emergency department visit for problem of high severity Facility 2022 66 67 $70,816 $6,837 9.7%
99283 Emergency department visit for problem of moderate severity Facility 2022 24 25 $17,721 $1,492 8.4%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 241 254 $400,558 $40,690 10.2%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2021 30 30 $55,440 $5,940 10.7%
99284 Emergency department visit, problem of high severity Facility 2021 52 53 $55,968 $5,562 9.9%
99283 Emergency department visit, moderately severe problem Facility 2021 21 22 $15,576 $1,405 9.0%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 336 350 $551,950 $53,604 9.7%
99291 Critical care delivery critically ill or injured patient, first 30-74 minutes Facility 2020 68 69 $127,512 $14,286 11.2%
99284 Emergency department visit, problem of high severity Facility 2020 56 58 $61,248 $6,100 10.0%
99283 Emergency department visit, moderately severe problem Facility 2020 30 31 $21,948 $1,806 8.2%
36556 Insertion of central venous catheter for infusion, patient 5 years or older Facility 2020 12 12 $15,483 $917.00 5.9%

About Dr. Michael Eagan, MD

Dr. Michael Eagan, MD is a Emergency Medicine healthcare provider based in Long Branch, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1003965237.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Eagan, MD has received a total of $113.43 in payments from pharmaceutical and medical device companies, with $20.00 received in 2024. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($93.43).

As a Medicare-enrolled provider, Eagan has provided services to 1,666 Medicare beneficiaries, totaling 1,727 services with total Medicare billing of $247,723. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Location Long Branch, NJ
  • Active Since 01/09/2007
  • Last Updated 06/08/2023
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1003965237

Products in Payments

  • XARELTO (Drug) $27.90
  • BRILINTA (Drug) $25.67
  • ELIQUIS (Drug) $24.96
  • Kcentra (Biological) $20.00
  • DALVANCE (Drug) $14.90

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Long Branch